Northwest Biotherapeutics, Inc. NWBO
Set alert
0.17 USD -0.01 -3.52%
As of Nov 3, 12:36 PM ET
0.1675 Day range 0.1758
0.15 52-week range 0.32
- YTD
- -26.17%
- 1 year
- -34.69%
- Open
- 0.1745
- Prev close
- 0.176
- Mkt cap
- 289.62M
- Vol
- 837.33K
- Avg vol
- 4.12M
- EPS
- -0.03
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 0.1675
- High
- 0.1758
- Forward P/E
- 0.00
- Beta
- 0.55
- Short ratio
- 13.54
- Inst. own
- 42.60%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 0.407273
- 200-d avg
- 0.457338
- 1y target
- 5.00
MAX chart
Events in this range
- Mar 5, 2024Earnings: -0.02; estimate 0; surprise —%
Signals (105)
| Name | Date | Ago |
|---|---|---|
| SMA: Bearish | Feb 1, 2026 | 9 months ago |
| SMA: Bullish | Jan 1, 2026 | 10 months ago |
| SMA: Bearish | Sep 1, 2025 | 1 year ago |
| SMA: Bullish | Aug 1, 2025 | 1 year ago |
| MACD: Buy Signal | Jun 1, 2025 | 1 year ago |
| SMA: Bearish | May 1, 2025 | 1 year ago |
| SMA: Bullish | Apr 1, 2025 | 1 year ago |
| MACD: Sell Signal | Feb 1, 2024 | 2 years ago |
| SMA: Bearish | Jan 1, 2024 | 2 years ago |
| SMA: Bearish | Oct 1, 2023 | 3 years ago |
| SMA: Bullish | Sep 1, 2023 | 3 years ago |
| SMA: Bullish | Sep 1, 2023 | 3 years ago |
| MACD: Buy Signal | Sep 1, 2023 | 3 years ago |
| SMA: Bearish | Jan 1, 2023 | 3 years ago |
| SMA: Bullish | Nov 1, 2022 | 4 years ago |
| SMA: Bearish | May 1, 2022 | 4 years ago |
| SMA: Bearish | May 1, 2022 | 4 years ago |
| SMA: Bullish | Apr 1, 2022 | 4 years ago |
| SMA: Bullish | Apr 1, 2022 | 4 years ago |
| SMA: Bearish | Mar 1, 2022 | 4 years ago |
Newest 20 of 105.
Analyst view
Consensus: buy
Buy
Price target (mean) 5.00
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 0.00 | 0.00 – 0.00 | 0.00 | 0.0% | 312.62M | 0.0% | 0 |
| Next quarter | 0.00 | 0.00 – 0.00 | 0.00 | 0.0% | 312.62M | 0.0% | 0 |
| Current year | 0.00 | 0.00 – 0.00 | 0.00 | 0.0% | 312.62M | 0.0% | 0 |
| Next year | 0.00 | 0.00 – 0.00 | 0.00 | 0.0% | 692.15M | +121.4% | 0 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Mar 11, 2014 | Oppenheimer | Downgrade | Outperform | Perform |
| Oct 15, 2013 | Oppenheimer | Initiated | — | Outperform |
| Sep 18, 2013 | Summer Street Research | Initiated | — | Buy |